制藥網(wǎng)
詳細介紹
| 瑞格列奈 |
| 糖尿病治療藥 藥代動力學(xué) 劑量和用法 臨床評價 不良反應(yīng) 注意事項 |
| 中文名稱: | 瑞格列奈 |
| 中文同義詞: | 基]丁基]氨基]-2-氧乙基]苯甲酸;瑞格列萘;(標準品);溶液,100PPM;(降糖藥);溶液溶液,1000PPM;,諾和龍; 500G |
| 英文名稱: | Repaglinide |
| 英文同義詞: | (S)-(+)-2-Ethoxy-4-[[[N-[1-(2-piperidinophenyl)-3-methylbutyl]amino]carbonyl]methyl]benzoic acid;Benzoic acid, 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)- 2-oxoethyl)-, (S)-;2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid;2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxo-ethyl]benzoic acid;2-ethoxy-4-[2-keto-2-[[(1S)-3-methyl-1-(2-piperidinophenyl)butyl]amino]ethyl]benzoic acid;Repaglinide,(S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid, Novonorm, Prandin;Repaglinide (200 mg)G0D2760.999mg/mg(ai);Repaglinide (200 mg) |
| CAS號: | 135062-02-1 |
| 分子式: | C27H36N2O4 |
| 分子量: | 452.59 |
| EINECS號: | |
| 相關(guān)類別: | 糖尿病治療藥;藥物;醫(yī)藥中間體;Aromatics;Heterocycles;API;Pharmaceutical raw material;DTIC-DOME;分析標準品;膜轉(zhuǎn)運/離子通道;其他獸藥標準品;醫(yī)藥原料;中間體;降血糖類;;原料;降壓降糖類;小分子抑制劑;離子通道;膜轉(zhuǎn)運;Pharmaceutical material and intermeidates;Active Pharmaceutical Ingredients;Chiral Reagents;Amino Acids 13C, 2H, 15N;Chemical Impurities;Impurities;Intermediates & Fine Chemicals;Pharmaceuticals;Amino Acids & Derivatives;原料藥;激素及其有關(guān)藥物 |
| Mol文件: | 135062-02-1.mol |
 | |
| 性質(zhì) |
| 熔點 | 129-130.2 °C |
| 儲存條件 | 2-8°C |
| 溶解度 | DMSO: 34 mg/mL |
| 形態(tài) | solid |
| 顏色 | white |
| CAS 數(shù)據(jù)庫 | 135062-02-1(CAS DataBase Reference) |
制藥網(wǎng)